Exploring Novel Treatment Options for Alopecia Areata
Panelists discuss how recent advancements, particularly the introduction of Janus kinase JAK inhibitors, are reshaping the treatment landscape for Aalopecia Aareata, offering new therapeutic options and addressing unmet needs in both efficacy and patient care.
Episodes
December 11th 2024EP. 1: Discussing the Pathophysiology of Alopecia Areata
Ryan Haumschild, PharmD, MS, MBA;Amy McMichael, MD ;Benjamin Ungar, MD ;Arash Mostaghimi, MD, MPH, FAAD ;Nicole Friedland
Panelists discuss how alopecia areata (AA) is a chronic autoimmune disease characterized by inflammation that attacks hair follicles, leading to hair loss and varying disease progression.
